company background image
ZBH logo

Zimmer Biomet Holdings NYSE:ZBH Voorraadrapport

Laatste prijs

US$108.18

Marktkapitalisatie

US$21.6b

7D

0.8%

1Y

2.6%

Bijgewerkt

08 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Zimmer Biomet Holdings, Inc.

NYSE:ZBH Voorraadrapport

Marktkapitalisatie: US$21.6b

ZBH Overzicht aandelen

Zimmer Biomet Holdings, Inc. is samen met haar dochterondernemingen wereldwijd actief als medisch technologiebedrijf.

Over het bedrijf

Beloningen

Verhandeld tegen 55.2% onder onze schatting van de reële waarde
De winst zal naar verwachting met 8.07% per jaar groeien
De winst groeide het afgelopen jaar met 128.4%
Handelen tegen een goede waarde vergeleken met branchegenoten en branchegenoten

Risicoanalyse

Grote eenmalige posten die de financiële resultaten beïnvloeden
Heeft een hoog schuldenniveau

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

Innovative Pipeline And Strategic Talent Drive Future Profitability And Growth

Key Takeaways Successful ERP implementation and strategic leadership enhance The analysts have a consensus price target of $124.92 for Zimmer Biomet Holdings based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $150.0, and the most bearish reporting a price target of just $107.0. In order for you to agree with the analyst's consensus, you'd need to believe that by 2027, revenues will be $8.6 billion, earnings will come to $1.3 billion, and it would be trading on a PE ratio of 21.7x, assuming you use a discount rate of 6.9%.
View narrative
US$124.92
FV
13.4% undervalued intrinsic discount
4.39%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
3 days ago author updated this narrative

Zimmer Biomet Holdings, Inc. Concurrenten

STERIS

NYSE:STE

US$21.3b

Hologic

NasdaqGS:HOLX

US$18.4b

IDEXX Laboratories

NasdaqGS:IDXX

US$35.5b

DexCom

NasdaqGS:DXCM

US$26.9b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Zimmer Biomet Holdings
Historische aandelenkoersen
Huidige aandelenkoersUS$108.18
52 Week HoogtepuntUS$133.90
52 Week LaagUS$101.47
Bèta1.02
11 maand verandering4.56%
3 maanden verandering0.093%
1 Jaar Verandering2.62%
33 jaar verandering-18.28%
5 jaar verandering-26.30%
Verandering sinds IPO263.51%

Recent nieuws en updates

Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality

Nov 07
Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality

Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 02
Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Recent updates

Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality

Nov 07
Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality

Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 02
Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up

Oct 03
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up

Zimmer Biomet: The Undervalued Titan Of Joint Replacements

Oct 02

Zimmer Biomet Stock: Don't Jump In At The 52-Week Low

Sep 19

We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)

Sep 18
We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)

Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24

Sep 02
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24

Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly

Aug 27
Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly

Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?

Jul 15
Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?

Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings

Jul 02
Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings

Zimmer Biomet: Brighter Prospects In H2 2024

Jul 02

Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24

Jun 19
Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24

When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?

Jun 05
When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?

Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24

May 21
Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24

Zimmer Biomet Holdings: Moving Along

May 17

The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising

May 02
The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising

Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?

Mar 20
Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?

Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24

Mar 02
Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24

Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality

Feb 15
Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality

What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?

Feb 11
What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?

Zimmer Biomet: Weight Loss Drug Concerns Are Overblown

Feb 05

A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Jan 29
A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'

Jan 20

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar

Jan 15
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar

The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing

Dec 31
The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing

Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution

Dec 18

Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly

Dec 17
Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly

Zimmer Biomet: Still Many Questions After A Solid Year So Far

Nov 26

When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?

Nov 06
When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?

Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching

Oct 07
Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching

Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes

Sep 21
Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes

Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence

Sep 14

Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Sep 06
Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy

Aug 11

Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?

Aug 08
Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?

Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?

Jul 10
Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?

We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease

Jun 27
We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease

Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement

Jun 13
Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement

A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

May 30
A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Zimmer Biomet: Expect Growth Momentum To Continue

May 26

Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?

May 04
Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?

At US$129, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?

Apr 02
At US$129, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?

Rendement voor aandeelhouders

ZBHUS Medical EquipmentUS Markt
7D0.8%1.6%5.0%
1Y2.6%31.5%36.1%

Rendement versus industrie: ZBH presteerde slechter dan de US Medical Equipment -sector, die het afgelopen jaar een rendement van 31.5 % opleverde.

Rendement versus markt: ZBH presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 36.1 % opleverde.

Prijsvolatiliteit

Is ZBH's price volatile compared to industry and market?
ZBH volatility
ZBH Average Weekly Movement3.6%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.2%
10% most volatile stocks in US Market15.2%
10% least volatile stocks in US Market2.9%

Stabiele aandelenkoers: ZBH heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van ZBH is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
192718,000Ivan Tornoswww.zimmerbiomet.com

Zimmer Biomet Holdings, Inc. is samen met haar dochterondernemingen wereldwijd actief als medisch technologiebedrijf. Het bedrijf ontwerpt, produceert en verkoopt orthopedische reconstructieve producten, zoals knie- en heupproducten; S.E.T.-producten, waaronder sportgeneeskunde, biologische producten, voet- en enkelproducten, extremiteiten en traumaproducten; craniomaxillofaciale en thoraxproducten, waaronder gezichts- en schedelreconstructieproducten, evenals producten die de botten van de borstkas fixeren en stabiliseren om genezing of reconstructie na open hartchirurgie, trauma of voor misvormingen van de borstkas te vergemakkelijken. Het bedrijf biedt ook robot-, chirurgische en botcementproducten.

Zimmer Biomet Holdings, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Zimmer Biomet Holdings zich tot de beurswaarde?
ZBH fundamentele statistieken
MarktkapitalisatieUS$21.64b
Inkomsten(TTM)US$1.08b
Inkomsten(TTM)US$7.60b

19.9x

Koers/Winstverhouding

2.8x

P/S-verhouding

Is ZBH overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
ZBH resultatenrekening (TTM)
InkomstenUS$7.60b
Kosten van inkomstenUS$2.13b
BrutowinstUS$5.46b
Overige uitgavenUS$4.38b
InkomstenUS$1.08b

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)5.44
Brutomarge71.90%
Nettowinstmarge14.27%
Schuld/Eigen Vermogen Verhouding53.6%

Hoe presteerde ZBH op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

0.9%

Huidig dividendrendement

18%

Uitbetalingsratio